Lilly, Pfizer invest in UK startup’s seed round for neurodegeneration protein degraders

A UK start­up that wants to bring pro­tein de­graders to the neu­rode­gen­er­a­tion field has closed a $31 mil­lion seed round.

The com­pa­ny is called Trimtech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.